Disc Medicine, Inc
Disc Medicine develops DISC-3405, an anti-TMPRSS6 monoclonal antibody designed to increase hepcidin production and suppress serum iron for iron overload diseases and polycythemia vera.
424B3Nov 6Latest SEC filing
Nov 5Latest story
November 2026
October 2026
September 2026
July 2026
June 2026